4Stener-Victorin E, Lindholm C. Immunity and beta-endorphin concentrations in hypothalamus and plasma in rats with steroid-induced polycystic ovaries: effect of low-h-equency electroacupuncture [ J ]. Biol Reprod, 2004,70 : 329-333
5Stener-Victorin E, Ploj K, Larsson BM, et al. Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity [ J ]. Reprod Biol Endocrinol,2005 ,3 :44-48
7Kaltsas GA, Androulakis II, Tziveriotis K, et al. Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly [ J ]. Clin Endocrinol (Oxf) ,2007,67:917-922
8Ke WX, Shan GQ, Hua SY. Different responses of insulin, C-peptide, and testosterone to an oral glucose tolerance test in two groups of women with polycystic ovarian syndrome [ J ]. Acta Obstet Gynecol Scand, 1996,75 : 166- 169
9Risma KA, Hirshfield AN, Nilson JH. Elevated luteinizing hormone in prepubertal transgenie mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology [ J]. Endocrinology, 1997,138:3540-3547
2Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring), 2006, 14 (Suppl 5): S242-S9.
3Juan CC, Au LC, Fang VS, et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Bophys Res Commun, 2001, 289(5): 1328-33.
4Baranova A, Gowder S J, Schlauc K, et al. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obes Surg, 2006, 16(9):1118-25.
5Tilmaz M, Bukan N, Ersoy R, et al. Glucose intolerance,insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.Hum Reprod, 2005, 20(9): 2414-20.
6Rajala MW, Obici S, Scherer PE, et al. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest, 2003,111(2): 225-30.
7Abdella NA, Mojiminiyi OA, Moussa MA, et al. Plasma leptin concentration in patients with type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance. Diabet Med, 2005, 22(3): 278-85.
8Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature, 2001,409(6818):307-12.
9Mook S, Halkes Cj C, Bilecen S, et al. hz vivo regulation of plasma free fatty acids in insulin resistance. Metabolism,2004, 53(9):1197-201.
10Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw, 2006, 17(1): 4-12.
6Solomon CG.The epidemiology of polycystic ovary syndrome:prevalenceand associated disease risks[J].Endocrinol Metab Clin North Am,1999;28:247-264.
7Zhang JQ,Cai WQ,Zhou DS,et al.Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats[J].Brain Res,2002;935(1-2):73-80.
8Liu B,Dluzen DE.Oestrogen and nigrostriatal dopaminergic neurodegeneration:animal models and clinical reports of Parkinson's disease[J].Clin Exp Pharmacol Physiol,2007;34(7):555-565.
